The redox state of glutathione regulates the hypoxic induction of HIF-1

European Journal of Pharmacology

Volumn 606, Issue 1-3, 2009, Pages 45-49

  Tajima, Masamichi ^a   Kurashima, Yukiko ^b   Sugiyama, Kenji ^c   Ogura, Tsutomu ^b   Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cobalt; Glutathione redox; HIF 1 (hypoxia inducible factor 1) induction; Hypoxia; VEGF (vascular endothelial growth factor)

Indexed keywords

ACETYLCYSTEINE; CARMUSTINE; EBSELEN; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE ETHYL ESTER; GLUTATHIONE PEROXIDASE; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION;

ACETYLCYSTEINE; ANIMALS; ANOXIA; AZOLES; CELL LINE, TUMOR; ENZYME INHIBITORS; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; ORGANOSELENIUM COMPOUNDS; OXIDATION-REDUCTION; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 61349095290     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.01.026     Document Type: Article

References (38)

1. Agani F.H., Pichiule P., Chavez J.C., and LaManna J.C. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J. Biol. Chem. 275 (2000) 35863-35867
2. Babson J.R., Abell N.S., and Reed D.J. Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes. Biochem. Pharmacol. 30 (1981) 2299-2304
3. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., and Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11715-11720
4. Chomczynsk P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
5. Duyndam M.C., Hulscher T.M., Fontijn D., Pinedo H.M., and Boven E. Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J. Biol. Chem. 276 (2001) 48066-48076
6. Fischer H., and Dereu N. Mechanism of the catalytic reduction of hydroperoxides by ebselen: A selenium-77 NMR study. Bull. Soc. Chim. Belg. 96 (1987) 757-768
7. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16 (1996) 4604-4613
8. Glass R.S., Farooqui R., Sabani M., and Ehler K.W. Formation of thiocarbonyl compounds in the reaction of ebselen oxide with thiols. J. Org. Chem. 54 (1989) 1092-1097
9. Haddad J.J. Oxygen homeostasis, thiol equilibrium and redox regulation of signaling transcription factors in the alveolar epithelium. Cell. Signal. 14 (2002) 799-810
10. Hur E., Chang K.Y., Lee E., Lee S.K., and Park H. Mitogen-activated protein kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol. Pharmacol. 59 (2001) 1216-1224
11. 2 sensing. Science 292 (2001) 464-468
12. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
13. Jiang B.H., Rue E., Wang G.L., Roe R., and Semenza G.L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271 (1996) 17771-17778
14. Kallio P.J., Wilson W.J., O, Brien S., Makino Y., and Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274 (1999) 6519-6525
15. Kelley M.R., and Parsons S.H. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1. Antioxid. Redox Signal. 3 (2001) 671-683
16. Kimura H., Weisz A., kurashima Y., Hashimoto K., Ogura T., D, Acquisto F., Addeo R., Makuuchi M., and Esumi H. Hypoxia response element of human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95 (2000) 189-197
17. Kosower N.S., and Kosower E.M. The glutathione status of cells. Int. Rev. Cytol. 54 (1978) 109-160
18. Laughner E., Taghavi P., Chiles K., Mahon P.C., and Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21 (2001) 3995-4004
19. Liu Q., Berchner-Pfannschmidt U., Moller U., Brecht M., Wotzlaw C., Acker H., Jungermann K., and Kietzmann T. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4302-4307
20. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
21. Michi Y., Morita I., Amagasa T., and Morita S. Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells. Oral Oncol. 36 (2000) 81-88
22. Page E.L., Robitaille G.A., Pouyssegur J., and Richard D.E. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 277 (2002) 48403-48409
23. Powis G., Briehl M., and Obong J. Redox signaling and the control of cell growth and death. Pharmacol. Ther. 68 (1995) 149-173
24. Russel J., Spickett C.M., Geglinski J., Smith W.E., McMurray J., and Abdullah I.B. Alterations in erythrocyte glutathione redox balance by N-acetylcyteine, captopril and endogenous glutathione. FEBS Lett. 347 (1994) 215-220
25. Richard D.E., Berra E., and Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275 (2000) 26765-26771
26. Salceda S., and Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272 (1997) 22642-22647
27. Salnikow K., Donald S.P., Bruick R.K., Zhitikovich A., Phang J.M., and Kasprzak K.S. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J. Biol. Chem. 279 (2004) 40337-40344
28. Semenza G.L. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35 (2000) 71-103
29. Semenza G.L. Targeting HIF-1 for cancer therapy. Nature Rev. 3 (2003) 721-732
30. Shatrov V.A., Sumbayev V.V., Zhou J., and Brune B. Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms. Blood 101 (2003) 4847-4849
31. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radic. Biol. Med. 14 (1993) 313-323
32. Stiehl D.P., Jelkmann W., Wenger R.H., and Hellwig-Burgel T. Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 512 (2002) 157-162
33. Suliman H.B., Ali M., and Piantadosi C.A. Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia. Blood 104 (2004) 43-50
34. Wang G.L., Jiang B.H., Rue E.A., and Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5510-5514
35. Welsh S.J., Bellamy W.T., Briehl M.M., and Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62 (2002) 5089-5095
36. Welsh S.J., Williams R.R., Birmingham A., Newman D.J., Kirkpatrick D.L., and Powis G. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. Mol. Cancer Ther. 2 (2003) 235-243
37. Zhong H., Agani F., Baccala A.A., Laughner E., Rioseco-Camacho N., Isaacs W.B., Simons J.W., and Semenza G.L. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res. 58 (1998) 5280-5284
38. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., Simons J.W., and Semenza G.L. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/ AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60 (2000) 1541-1545